AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2018

Sep 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2018-09-11

Reporting Person: MARAGANORE JOHN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-11	Common stock	S	11155	$72.52	Disposed	38609	Direct
2018-09-11	Common stock	S	2400	$73.82	Disposed	36209	Direct
2018-09-12	Common stock	S	14162	$71.74	Disposed	22047	Direct

Footnotes

F1: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $72.27 to $72.89. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $73.33 to $74.25. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $71.70 to $72.17. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.